Abstract: A display device includes sub-pixels corresponding to sub-pixel areas. Each of the sub-pixels includes a display unit including a light-emitting layer which emits light, and a reflection control layer disposed over the sub-pixel areas on the display unit, where the reflection control layer selectively absorbs light in a wavelength band. The reflection control layer includes a first layer and a second layer disposed on the first layer, where the second layer has a thickness less than a thickness of the first layer. The second layer includes a liquid repellent material.

Abstract: The present invention relates to a composite formulation for oral dosage that comprises an API selected from 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof and does not comprise a pH modifier as an excipient. Since the composite formulation for oral dosage according to the present invention does not comprise a pH modifier, it has the advantage of having a high level of dissolution rate as well as enhanced dosing convenience and productivity, in spite of comprising a high content of API.

Abstract: A display device includes first to third light emitting units disposed on a substrate, an encapsulation layer disposed on the first to third light emitting units, a sensor electrode disposed on the encapsulation layer, an insulating layer disposed on the sensor electrode, first to third color filters disposed on the touch insulating layer and overlapping the first to third light emitting units in a thickness direction of the substrate, respectively. The sensor electrode overlaps at least one of the first color filter, the second color filter, and the third color filter in the thickness direction of the substrate.

Abstract: The present invention relates to a composite formulation for oral administration comprising an active pharmaceutical ingredient (API) selected from 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof, wherein the API has a particle size of granules corresponding to 90% of the maximum particle size in the cumulative particle size distribution (D(0.9)) of 80 ?m or more and 300 ?m or less. The composite formulation for oral administration according to the present invention has a low friability and an increased dissolution rate even if a high content of API is included, by regulating the particle size of the API to a certain range.

Abstract: The present invention relates to an oral formulation comprising an API selected from 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazol-4-carboxylic acid or a pharmaceutically acceptable salt thereof in high content. Since the oral formulation according to the present invention has a high content and excellent physical properties by comprising a glidant in excipients, economic efficiency and the convenience of administration can be increased.

Abstract: A display device includes first to third light emitting units disposed on a substrate, an encapsulation layer disposed on the first to third light emitting units, a sensor electrode disposed on the encapsulation layer, an insulating layer disposed on the sensor electrode, first to third color filters disposed on the touch insulating layer and overlapping the first to third light emitting units in a thickness direction of the substrate, respectively. The sensor electrode overlaps at least one of the first color filter, the second color filter, and the third color filter in the thickness direction of the substrate.

Abstract: There are provided a display device having dual color filter patterns and a manufacturing method thereof. The liquid crystal display device includes an array substrate including first color filter patterns, a counter substrate including second color filter patterns, and a liquid crystal layer interposed between the array substrate and the counter substrate, wherein the first color filter patterns and the second color filter patterns include photoresists having different color coordinates.

Abstract: There are provided a display device having dual color filter patterns and a manufacturing method thereof. The liquid crystal display device includes an array substrate including first color filter patterns, a counter substrate including second color filter patterns, and a liquid crystal layer interposed between the array substrate and the counter substrate, wherein the first color filter patterns and the second color filter patterns include photoresists having different color coordinates.

Abstract: A color filter composition is provided. The color filter composition according to an exemplary embodiment includes a colorant A including a pigment or a dye, a binder resin B, an initiator C, and an assistance colorant D, wherein the initiator absorbs light of an ultraviolet wavelength, and the assistance colorant has a transmittance of more than 60% between about wavelengths 300 nm to 400 nm.

Abstract: The present invention relates to a sustained release drug delivery system composed of a water insoluble polymer, and more particularly, to a sustained release drug delivery system comprising: a crystalline core material; an active ingredient layer which is formed on an outer surface of the crystalline core material and comprises a pharmacologically active ingredient and a water insoluble polymer; and a sustained release layer which is formed on an outer surface of the active ingredient layer and comprises a sustained release film forming material. The present invention also relates to a sustained release drug delivery system which releases an effective drug in an aqueous solution or a body fluid for 24 hours by using a sustained release film forming material and a plasticizer together to provide sustained release of a pharmacologically active ingredient.